Michelle Powell
About Michelle Powell
Michelle Powell is the Manager of GxP Controlled Documents and Training at Arcus Biosciences, where she has worked since 2021. She has extensive experience in the pharmaceuticals industry, with a background in cross-functional team leadership and compliance.
Work at Arcus Biosciences
Michelle Powell has been serving as the Manager of GxP Controlled Documents and Training at Arcus Biosciences since 2021. In this role, she oversees the management of Good Practice (GxP) controlled documents and training programs, ensuring compliance with industry regulations. Her responsibilities include developing and implementing strategies for document control and training within the organization, contributing to the overall operational efficiency of Arcus Biosciences.
Education and Expertise
Michelle Powell earned a Bachelor of Arts (B.A.) in Spanish Language and Literature from San Francisco State University. She possesses expertise in cross-functional team leadership and strategy, particularly within the pharmaceuticals industry. Her educational background, combined with her professional experience, equips her with the necessary skills to navigate complex regulatory environments and lead teams effectively.
Background in Pharmaceuticals
Michelle Powell has extensive experience in the pharmaceuticals sector, having worked in various roles that emphasize documentation and compliance. Prior to her current position, she served as a Manufacturing Documentation Specialist at Bayer HealthCare from 1995 to 2003 and at XOMA from 2009 to 2012. Additionally, she worked as a Document Control Specialist at BeiGene from 2019 to 2021. This diverse background has provided her with a strong foundation in GxP and data integrity.
Skills in GxP and Data Integrity
Michelle Powell possesses strong skills in GxP and data integrity, which are essential for maintaining compliance in pharmaceutical operations. Her expertise in these areas enables her to ensure that all documentation and training processes adhere to regulatory standards. This focus on compliance is critical in the pharmaceutical industry, where adherence to GxP guidelines is necessary for the safety and efficacy of products.